Serum Uric Acid to Creatinine Ratio and Risk of Metabolic Syndrome in Saudi Type 2 Diabetic Patients.

about

Relationships of Hyperhomocysteinemia and Hyperuricemia With Metabolic Syndrome and Renal Function in Chinese Centenarians

P2860

Q57113237-4E8F4C7E-40FC-413A-8BED-21961121CC40

P2860

Serum Uric Acid to Creatinine Ratio and Risk of Metabolic Syndrome in Saudi Type 2 Diabetic Patients.

Item

http://www.wikidata.org/entity/Q42136564

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Serum Uric Acid to Creatinine ...... audi Type 2 Diabetic Patients.

@en

Serum Uric Acid to Creatinine ...... audi Type 2 Diabetic Patients.

@nl

type

Item

label

Serum Uric Acid to Creatinine ...... audi Type 2 Diabetic Patients.

@en

Serum Uric Acid to Creatinine ...... audi Type 2 Diabetic Patients.

@nl

prefLabel

Serum Uric Acid to Creatinine ...... audi Type 2 Diabetic Patients.

@en

Serum Uric Acid to Creatinine ...... audi Type 2 Diabetic Patients.

@nl

P1476

Serum Uric Acid to Creatinine ...... audi Type 2 Diabetic Patients.

@en

P2093

Majed S Alokail

http://www.w3.org/2001/XMLSchema#string

Omar S Al-Attas

http://www.w3.org/2001/XMLSchema#string

Shaun Sabico

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country

Metabolic syndrome and kidney disease: a systematic review and meta-analysis

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study.

Diabetes mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (Riyadh cohort 2): a decade of an epidemic.

Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?

Uric acid: a novel mediator and marker of risk in chronic kidney disease?

Hyperuricemia and renal function.

Metabolic syndrome: Risk factors among adults in Kingdom of Saudi Arabia.

Metabolic syndrome and chronic kidney disease: Current status and future directions.

P2888

s41598-017-12085-0

P304

12104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-12085-0

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nasser M Al-Daghri

Kaiser Wani

P577

2017-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091807489

http://www.w3.org/2001/XMLSchema#string

P698

28935934

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

P932

5608718

http://www.w3.org/2001/XMLSchema#string

Serum Uric Acid to Creatinine Ratio and Risk of Metabolic Syndrome in Saudi Type 2 Diabetic Patients.

about

P2860

P2860

Serum Uric Acid to Creatinine Ratio and Risk of Metabolic Syndrome in Saudi Type 2 Diabetic Patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932